Hudock, Inc. Abbott Laboratories Transaction History

Hudock, Inc.

$578 Million
Q3 2024

A detailed history of Hudock, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Hudock, Inc. holds 3,409 shares of ABT stock, worth $389,410. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,409

Previous 3,251 4.86%

Holding current value

$389,410

Previous $337,000 15.13%

% of portfolio

0.07%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$100.07 - $118.13 $15,811 - $18,664	158 Added 4.86%	3,409 $388,000
Q2 2024 Aug 02, 2024	BUY	$100.73 - $112.44 $805 - $899	8 Added 0.25%	3,251 $337,000
Q1 2024 May 02, 2024	BUY	$109.52 - $120.96 $438 - $483	4 Added 0.12%	3,243 $368,000
Q4 2023 Jan 22, 2024	SELL	$90.19 - $110.4 $6,042 - $7,396	-67 Reduced 2.03%	3,239 $356,000
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $30,187 - $36,219	316 Added 10.57%	3,306 $320,000
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $5,240 - $5,839	52 Added 1.77%	2,990 $325,000
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $13,850 - $16,303	143 Added 5.12%	2,938 $297,000
Q4 2022 Feb 08, 2023	BUY	$95.06 - $111.52 $166,545 - $195,383	1,752 Added 167.98%	2,795 $306,000
Q3 2022 Nov 02, 2022	SELL	$96.76 - $112.03 $50,315 - $58,255	-520 Reduced 33.27%	1,043 $100,000
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $20,311 - $24,550	-199 Reduced 11.29%	1,563 $169,000
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $17,445 - $21,273	153 Added 9.51%	1,762 $208,000
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $28,073 - $34,374	-243 Reduced 13.12%	1,609 $226,000
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $466 - $516	4 Added 0.22%	1,852 $218,000
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $317 - $373	3 Added 0.16%	1,848 $214,000
Q1 2021 Apr 26, 2021	BUY	$108.84 - $128.23 $326 - $384	3 Added 0.16%	1,845 $221,000
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $21,210 - $23,112	202 Added 12.32%	1,842 $201,000
Q3 2020 Oct 23, 2020	BUY	$91.64 - $111.29 $30,424 - $36,948	332 Added 25.38%	1,640 $178,000
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $5,895 - $7,546	77 Added 6.26%	1,308 $119,000
Q1 2020 Apr 27, 2020	BUY	$62.82 - $91.86 $9,485 - $13,870	151 Added 13.98%	1,231 $97,000
Q4 2019 Jan 21, 2020	BUY	$78.51 - $87.4 $314 - $349	4 Added 0.37%	1,080 $93,000
Q3 2019 Oct 31, 2019	BUY	$81.84 - $88.74 $45,012 - $48,807	550 Added 104.56%	1,076 $90,000
Q2 2019 Jul 30, 2019	SELL	$72.88 - $85.0 $7,433 - $8,670	-102 Reduced 16.24%	526 $44,000
Q1 2019 Apr 23, 2019	BUY	$66.22 - $80.06 $1,655 - $2,001	25 Added 4.15%	628 $50,000
Q4 2018 Jan 29, 2019	BUY	$65.56 - $74.27 $65 - $74	1 Added 0.17%	603 $42,000
Q3 2018 Oct 16, 2018	BUY	$60.81 - $73.36 $60 - $73	1 Added 0.17%	602 $44,000
Q2 2018 Aug 01, 2018	BUY	$57.57 - $63.54 $172 - $190	3 Added 0.5%	601 $36,000
Q1 2018 Apr 27, 2018	BUY	$56.27 - $63.62 $112 - $127	2 Added 0.34%	598 $35,000
Q4 2017 Jan 30, 2018	BUY	$53.68 - $57.47 $107 - $114	2 Added 0.34%	596 $34,000
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $144 - $160	3 Added 0.51%	594 $31,000
Q2 2017 Aug 08, 2017	BUY	N/A	591	591 $28,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hudock, Inc. with notifications on news.

Account